Abstract: Chemically strengthened lithium aluminosilicate glass is characterized by a surface compression of at least 100,000 psi and a compression case depth of at least 600 microns. The glass also may be characterized by a compression at 50 microns below a surface of the glass that is at least 30,000 psi. A method of making this glass includes providing a lithium aluminosilicate glass having a composition comprising (in weight %): Li2O in an amount ranging from 3 to 9%, Na2O+K2O in an amount not greater than 3%, and Al2O3 in an amount ranging from 7 to 30%. The composition provides the glass with an annealing point temperature of at least 580° C. A mixed potassium and sodium salt bath is provided comprising predominantly potassium salt. A ratio of moles of sodium salt to moles of potassium salt in the mixed salt bath can range from 1:10 to 1:2. The temperature of the salt bath is maintained in a range of 450° C. up to an annealing point temperature of the glass.

Abstract: The present invention relates to the use of a enzyme treated fish protein hydrolyzate (FPH). The FPH material lowers the concentration of cholesterol in plasma, and triglycerides in the liver. FPH also induces a favorable change in the fatty acid pattern, and lowers the concentration of homocysteine in plasma. A preferable embodiment of the invention relates to the use of FPH as an anti-atherogenic and cardio protective agent, either given as a pharmaceutical or as a functional food.

Abstract: Apparatus and methods for hydrolyzing protein-containing raw material into water soluble protein and other products. The apparatuses and methods include an optional collection or processing stage in which protein-containing raw material, such as fish or animal carcasses from food production plants, are collected and optionally processed. The raw material is then reacted with one or more enzymes to hydrolyze the protein present, after which the one or more enzymes are inactivated and the components separated. The processes and apparatuses, which can be run as a batch processes or, advantageously as a continuous processes, can yield water soluble protein, oils, bone meal and other products that have utility as food or food additives.

Abstract: The present invention relates to the use of a compound of the formula Lys-X where X is a hydroxyl group, an amino group, alkoxy, Pro or Pro-Thr, or of a pharmaceutically acceptable salt thereof, for the treatment of inflammations. The invention also relates to the use of ?MSH for inducing tolerance.

Abstract: Methods of sol-gel processing for the preparation of mixed gels and nanoparticles are described. Further, mixed gels and nanoparticles obtained by the method are also disclosed. More specifically, a process for mixture of NiO nanoparticles and Yttria stabilized Zirconia nanoparticles obtained by only one sol-gel process is described.

Abstract: Hybrid polypeptides comprising at least two different allergenic proteins or fragments thereof wherein each fragment consists of at least eight consecutive amino acids of the respective allergenic protein are disclosed. The hybrid polypeptides and polynucleotides coding therefor can be used as pharmaceutical compositions, in particular as vaccines.

Abstract: An anti-biofouling seismic streamer casing (100,100?) is provided that is formed by a flexible tubing (110) coated with a layer of a two-part heat cured silicone elastomer (120). The seismic streamer casing (100, 100?) is formed by a method that includes steps of providing a flexible tubing (200) and pre-treating the outer surface of the tubing (210). Two parts of a two-part silicone elastomer are then mixed together (220). The method also includes coating the mixed two-part silicone elastomer on the flexible tubing (230), and heating the flexible tubing to cure the coating (240).

Abstract: The present invention relates to oral pharmaceutical preparations in the form of pellets in which a benzimidazole compound is stabilized by combining it with microcrystalline cellulose.

Abstract: The present invention describes a pharmaceutical, veterinary or alimentary composition comprising one or more bacterial strains capable of lowering the concentration of intestinal pathogenic peptides by means of peptidases of probiotic strains. The invention also relates to the use of such compositions, and a method for selection of probiotic strains. Also, the invention relates to novel bacterial strains.

Abstract: The present invention relates to a method for detecting and/or identifying Gram-positive bacteria with high GC content, in particular mycobacteria. The method comprises a nucleic acid amplification reaction and a subsequent hybridization reaction with suitable primers and probes. The invention furthermore relates to oligonucleotides, compositions, solid phases and kits which may be used for carrying out the method of the invention.

Abstract: A universal battery charger is described for accommodating a range of batteries. An adapter or connector is provided for each different type of battery which engages the standard housing including the main power supply. The adapter includes electronics which control the charging process, customised for each battery type. The adapter forms the front part of the charger and slides in from the front.